Tag: Robbins LLP

HELE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Helen of Troy Limited. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Helen of Troy Limited (HELE) Misled Investors Regarding the Ability of Project Pegasus to Improve Efficiency

BMI Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in Badger Meter, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Badger Meter, Inc. (BMI) Concealed Weakening Demand and Deteriorating Near-Term Order Trends

BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company’s Officers and Directors to Determine if They Violated...

BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if T

Investor Alert: Robbins LLP Informs Investors of the Altimmune, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability of its IMPACT Phase 2b MASH Trial

Investor Alert: Robbins LLP Informs Investors of the Lineage, Inc. Class Action Lawsuit

Investor Notice: Robbins LLP Informs Investors of the Sable Offshore Corp. Class Action

Robbins LLP is Investigating Allegations that Sable Offshore Corp. (SOC) Misled Investors Regarding Oil Production.

LAZR Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Lawsuit Against Luminar Technologies, Inc.

Robbins LLP is Investigating Allegations that Luminar Technologies, Inc. (LAZR) Failed to Disclose that its President and CEO was Engaged in Misconduct

Shareholder Alert: Robbins LLP Informs Investors of the Flywire Corporation Class Action

Robbins LLP is Investigating Allegations that Flywire Corporation (FLYW) Misled Investors Regarding its Business Prospects

CAPR Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Capricor Therapeutics, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Capricorn Therapeutics, Inc. (CAPR) Misled Investors Regarding the Viability of Deramiocel

CNC Class Action Alert: Robbins LLP Reminds Centene Corporation Stockholders of the Lead Plaintiff Deadline in the Class Action Against CNC

Robbins LLP is Investigating Allegations that Centene Corporation (CNC) Misled Investors Regarding its Business Prospects

SJM Stockholders Who Suffered Financial Losses Should Contact Robbins LLP About its Investigation into the Officers and Directors of J.M. Smucker Company

SAN DIEGO, July 10, 2025 /PRNewswire/ -- Shareholder rights law firm Robbins LLP is investigating The J.M. Smucker Company (NYSE: JSM) to determine whether certain J.M.Smuckers...

Fortrea Holdings Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Pending Against FTRE

Robbins LLP is Investigating Allegations that Fortrea Holdings, Inc. (FTRE) Misled Investors Regarding the Progress of its Pre-Spin Projects

TEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Tempus AI, Inc. Class Action

Robbins LLP is Investigating Allegations that Tempus AI, Inc. (TEM) Misled Investors Regarding its Business Prospects

RCKT Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Rocket Pharmaceuticals, Inc.

Robbins LLP is Investigating Allegations that Rocket Pharmaceuticals, Inc. (RCKT) Misled Investors Regarding the Viability and Efficacy of RP-A501

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsRobbins LLP

Dongfeng Liuzhou Motor’s 10th “67 Brand Customer Day” Advancing New Pathways for Global Growth

Vision Insurance After Retirement (2026): VSP Vision Care Named Leading Option for Retiree Eye Coverage by Expert Consumers